No not directly related, I think. I found some info, not the pretty blurb I read but I will keep looking.
From https://www.business.gov.au/assista...projects-crc-ps/current-crc-p-selection-round
Column 1 Column 2 Column 3 0 Allogeneic Stem Cell Cancer Immunotherapies Cartherics Pty LtdMesoblast LimitedCell Therapies Pty LtdHudson Institute of Medical ResearchMonash University This CRC-P will develop “off-the-shelf” immunotherapy products for cancer. As few as 3 rare triple HLA homozygous donor cells are histocompatible with a large percentage (~50%) of the Australian population. These will be used to create haplotype induced pluripotent stem cells (iPSCs) that can be infinitely expanded. These iPSCs will be gene edited and differentiated to become cytotoxic T cells with multiple targeting receptors for use in clinical trials of relapsed ovarian and gastric cancers.
None of the companies mentioned produced the info I read.
Cell Therapy News/Articles, page-135
-
- There are more pages in this discussion • 17,646 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |